Paydirt
DE
Insider

David V Elkins

EVP, Chief Financial Officer

David V Elkins (EVP, Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Bristol-Myers Squibb Company (BMY). The largest single filing was $1.9M of BMY (30,000 sh across 2 lots, as filed), executed Apr 1.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.9M
shares × price, as filed
Last traded
Apr 1
Filed Apr 2

Median ADV $761.0M across their filed names

Open performance
Volume by month
$2.7M$1.3M$0Oct 2024Apr 2025Oct 2025Apr 2026Sep 2025 · sells $2.7MApr 2026 · sells $1.9M
Buys $0 Sells $4.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
BMY Bristol-Myers Squibb Company BMY · 0 buys · 2 sells 2 filings
Recent filings
BMYSALE Bristol-Myers Squibb Company View filing → $1.9M
30,000 sh across 2 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET
BMYSALE Bristol-Myers Squibb Company View filing → $2.7M
56,000 sh × $47.33
Exec Sep 2 2025
Filed Sep 3 2025 · 5:30 PM ET